$36,655,675

Department of Health and Human Services·Office of Assistant Secretary for Preparedness and Response

healthactiveONGOING · MOD OF 2022 CONTRACT

WORK BEGAN2022-09-30·LATEST ACTION2026-03-27·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75A50122C00070_7505_-NONE-_-NONE-

Award description

THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO DEVELOP AND COMMERCIALIZE A RAPID PHENOTYPIC ANTIMICROBIAL SUSCEPTIBILITY TESTING (AST) SYSTEM THAT WILL DELIVER RESULTS FOR DEFINITIVE THERAPEUTIC DECISIONS WITHIN 4 TO 6 HOURS FROM COLONIES ON A CULTURE

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Develop a rapid antimicrobial susceptibility testing system delivering clinical diagnostic results within 4-6 hours.

Sub-sectors

clinical-diagnosticsantimicrobial-testingpandemic-preparedness

Why this matters

Enables faster targeted antibiotic therapy to reduce antimicrobial resistance and improve pandemic preparedness.

Supply-chain signal

Supports advanced diagnostic equipment platform development and clinical laboratory infrastructure capacity at Beckman Coulter.

Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-06-15. Cost: $0.010248.

Period of performance

Start

2022-09-30

End

2026-09-29

Status

activein 91 days

Recipient

BECKMAN COULTER, INC

UEI PU6HHX2R11C7

View full profile →

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_75A50122C00070_7505_-NONE-_-NONE-.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.